Latest Los Angeles Biomedical Research Institute Stories
Viral failure twice as common in patients with high viral loads given Epzicom when compared to those treated with Truvada.
Research team reviews outcomes after 2 years of treatment with ambrisentan.
Trauma patients who were intoxicated before their injuries were more likely to survive than trauma patients who suffered similar injuries but were sober at the time.
Rare genetic disorder may benefit from development of new dementia treatments.
The Southern California Biomedical Council (SoCalBio) - a member-supported trade association that serves biotech and medical device firms, research organizations and academic institutions throughout the Greater Los Angeles region - has announced that 22 early- to late-stage companies are confirmed to present at the 10th Annual SoCalBio Investor Conference, which will be held September 19th at the Wilshire Grand Hotel in downtown Los Angeles.
By Melissa Evans After years of clinical trials and research, Dr. Yutaka Niihara came up with a treatment for sickle cell anemia that was so simple he almost didn't believe it.